| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9743 | 
      | Human Intestinal Absorption | HIA+ | 0.9906 | 
      | Caco-2 Permeability | Caco2+ | 0.7086 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8415 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9727 | 
                                                     | Non-inhibitor | 0.9836 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9154 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.6296 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7952 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8412 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7909 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8906 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9500 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9695 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9675 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9845 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9133 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9482 | 
                                                                    | Non-inhibitor | 0.9717 | 
      | AMES Toxicity | Non AMES toxic | 0.9601 | 
      | Carcinogens | Carcinogens  | 0.6890 | 
      | Fish Toxicity | Low FHMT | 0.6099 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.6878 | 
      | Honey Bee Toxicity | High HBT | 0.8156 | 
      | Biodegradation | Ready biodegradable | 0.6368 | 
      | Acute Oral Toxicity | III | 0.7121 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5026 |